This Week's 'Barron's' Roundup
Tech stocks that are takeover targets, managed-care stocks that are poised to rally, plus much more.
09:44AM 10/25/09
Biotech Stock Mailbag: Oncothyreon
Readers write in about Oncothyreon, Progenics, Chelsea Therapeutics and more.
07:00AM 10/16/09
Early Movers: Pump Up the Volume
Several small-cap stocks were poised to move on above-average volume Wednesday.
08:40AM 10/14/09
Progenics Regains Relistor Rights
Progenics regains worldwide rights to Relistor from Wyeth in a deal that will provide Progenics with $10 million to aid in the transition.
08:13AM 10/14/09
Earnings Roundup: A&P, Progenics Pharma
Earnings roundup: Great Atlantic & Pacific Tea posts 4Q loss, Progenics Pharma 1Q loss narrows
10:27AM 05/12/09
Progenics 1Q Loss Narrows; Cuts Staff And Spending
Progenics Pharmaceuticals' 1st-qtr loss narrows on boost in revenue, lower costs; cuts jobs
09:02AM 05/12/09
Did Ardea's HIV Drug Catch the Bouquet?
Idenix coupled with Glaxo on its HIV drug IDX899, and now investors are eager to see how long Ardea's RDEA806 will remain single.
10:56AM 02/09/09
Biotech Scorecard: My Best and Worst Calls
Biotech expert Adam Feuerstein grades his hits and misses for 2008.
06:59AM 01/02/09
Biotech Mailbag: Savient's Unpleasant Surprise
Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.
03:19PM 10/31/08
Biotech Mailbag: Savient's Unpleasant Surprise (RealMoney.com $)
Savient Pharmaceuticals on Monday released new safety data linking its gout drug Puricase to serious cardiovascular side effects.
07:10AM 10/31/08
Notable News (Biotech Select $)
Here's an in-depth look at drug data presented by several biotech names at recent medical conferences. Also, updates on some model portfolio names.
09:21AM 10/29/08
Calpine Insider Buys $21.2 Million Worth
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:26AM 10/27/08
Biotech Stocks Burn Higher on M&A Fire
The sector is trading higher on today's buyout bid. One analyst offers a list of who else could tie the knot in the drug and biotech space.
12:44PM 07/31/08
Here'a a quick round-up of non-ImClone related news from this weekend's American Society of Clinical Oncology meeting.
09:11AM 06/02/08



Connect with TheStreet